Core Scientific (CORZ) has been in focus after securing a multi year, global partnership as Official Data Center Partner to the Cadillac Formula 1 Team, highlighting demand for its high density computing and data center capabilities.

Against this backdrop, Core Scientific’s recent news sits alongside a 7 day share price return of 10.97% and a 90 day share price return of 7.92%. The 1 year total shareholder return of 87.17% signals strong momentum despite a 30 day share price pullback of 7.57% from the current US$16.49 level.

If this data center pivot has your attention, it could be a good moment to see what else is moving in AI infrastructure, starting with our 35 AI infrastructure stocks.

With Core Scientific’s share price gains, new data center deals and fresh funding in play, the key question now is simple: are investors looking at an undervalued AI infrastructure pivot, or is the market already pricing in future growth?

Most Popular Narrative: 38.5% Undervalued

Core Scientific’s most followed narrative puts fair value at $26.82 versus the last close of $16.49, which is a wide gap for investors to weigh.

Updated models increasingly assume that Core Scientific will monetize its substantial power pipeline through high performance compute and AI infrastructure, which is seen as a structurally higher growth, higher multiple opportunity than pure Bitcoin mining.

Curious what justifies that higher fair value tag? This narrative leans heavily on rapid revenue expansion, a sharp earnings swing, and richer future profit margins. The full set of assumptions is where the story really gets interesting.

Result: Fair Value of $26.82 (UNDERVALUED)

However, that upside case still depends on a major shift from Bitcoin mining to high performance compute proceeding smoothly and on CoreWeave remaining a key customer.

Another View: Rich Sales Multiple Raises the Bar

The popular fair value story presents Core Scientific as 38.5% undervalued, but its current P/S of 16.3x tells a tougher story. That is higher than the US Software industry at 3.4x, above peers at 14.3x, and more than triple its own fair ratio of 5.1x.

If the market were to move closer to that fair ratio, today’s price could appear demanding rather than cheap, particularly for a business that is still loss making and carries negative equity. The key question is whether you believe future execution justifies paying this kind of premium.

Next Steps

If this mix of optimism and caution feels familiar, do not wait on others to decide the story for you. Review the 1 key reward and 2 important warning signs and weigh the full picture yourself.

Ready for more investment ideas?

If Core Scientific has sparked fresh questions, do not stop here. Broaden your watchlist with other focused stock ideas built from real numbers, not headlines.

• Target value opportunities that balance quality with price by checking out our 48 high quality undervalued stocks and see which companies currently stand out.
• Prioritise resilience and capital strength by scanning the solid balance sheet and fundamentals stocks screener (42 results) so you are not caught off guard by fragile finances.
• Spot potential early stage opportunities before the crowd by using the screener containing 26 high quality undiscovered gems and keep your idea pipeline one step ahead.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.